Back to Funding Hub
NIH SBIR/STTR
NIH SBIR/STTR: Health and Biotech Innovation Funding 2026
Funding Amount
Phase I: $314K | Phase II: $2.1M | CRP: $4.2M
Program Overview
NIH operates the largest SBIR/STTR program in the federal government, funding innovations in health, biomedical research, medical devices, therapeutics, diagnostics, and digital health technologies.
CRITICAL 2026 UPDATE: All NIH SBIR/STTR NOFOs expired October 1, 2025 due to program authorization lapse. Awaiting Congressional reauthorization.
Funding Levels (FY 2026)
Phase I: $314,363 (6 months to 2 years)
Phase II: $2,095,748 (1-3 years)
Commercialization Readiness Pilot (CRP): Up to $4,191,495 (up to 3 years)
Note: Individual NIH Institutes and Centers can set their own budget limits.